SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
SGLT2 Inhibition With Empagliflozin in Fontan Circulatory Failure	Cardiovascular Abnormalities, Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, cardiovascular disorder, congenital heart disease, heart disorder	Recruiting	Phase 3	2026-09-02		NCT06955260

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Applied Health Research Centre	6
Boehringer Ingelheim	158
Subodh Verma	3

2 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
St. Paul's Hospital	Vancouver	Canada	28
University Health Network	Toronto	Canada	50

Clinical trials